FDA approves leucovorin for a rare brain condition, not autism
TL;DR Summary
The FDA approved leucovorin for cerebral folate deficiency and clarified it is not approved to treat autism; data on autism efficacy is insufficient, though doctors may prescribe it off-label, and prescriptions rose after earlier statements from officials.
- FDA approves new use of synthetic vitamin B9 — but not for autism symptoms NBC News
- FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment CNBC
- FDA approves generic drug for rare brain disorder but not autism KOMO
- FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism The Hill
- FDA Approves Drug Trump Touted for Autism to Treat Other Neurological Disorder WSJ
Reading Insights
Total Reads
1
Unique Readers
4
Time Saved
3 min
vs 4 min read
Condensed
95%
717 → 37 words
Want the full story? Read the original article
Read on NBC News